,outcome,arm 1,arm 2,comparative statistic,95% CI,p-value,note
0,intervention,TLC D-99 patients,doxorubicin patients,,,,
0,Protocol-defined cardiotoxicity,13 %,29 %,NR,NR,NR,NR
0,CHF,2 cases,9 cases,NR,NR,NR,NR
